David Wullimann

The Karolinska KI/K COVID‐19 immune atlas: An open resource for immunological research and educational purposes

H. Ljunggren, J. Klingström, O. Rooyackers, 2022, Scandinavian journal of immunology.

Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination

A. Sette, H. Ljunggren, P. Ljungman, 2022, Immunity.

MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine

H. Ljunggren, G. Bogdanovic, K. Loré, 2022, Molecular medicine.

T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial

H. Ljunggren, A. Österborg, J. Lundin, 2022, Haematologica.

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Morten Nielsen, David A. Price, Annika Olsson, 2020, Cell.

Elevated CD21low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency

H. Ljunggren, M. Buggert, P. Bergman, 2022, Journal of Clinical Immunology.

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial

S. Hober, H. Ljunggren, P. Ljungman, 2021, EBioMedicine.

NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals

H. Ljunggren, E. Alici, P. Ljungman, 2022, Molecular medicine.

Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination

A. Sette, H. Ljunggren, A. Grifoni, 2022, Blood.

Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age

F. Lund-Johansen, H. Ljunggren, A. Karlsson, 2023, Proceedings of the National Academy of Sciences of the United States of America.

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID

H. Ljunggren, P. Ljungman, G. Bogdanovic, 2023, EBioMedicine.